Faculty at Huntsman Cancer Institute (HCI) cultivate the scientists who will carry our lifesaving work into the future. It’s part of our mission. We offer trainee programs for researchers, public health professionals, and care providers such as physicians and advanced practice clinicians. These are some of the more than 425 students training at HCI.
cancer research News
In 2018, a team of researchers at Huntsman Cancer Institute (HCI) received a prestigious National Cancer Institute Cancer Moonshot grant. The grant will fund studies about ways to identify patients who may benefit from genetic counseling and services.
The Precision Exercise Prescription (PEP) study is a unique collaboration between medical doctors, researchers, physical therapists, and patients. The study looks at how an exercise program tailored for each patient can improve long-term outcomes after lung cancer surgery.
Cornelia Ulrich, PhD, executive director of the Comprehensive Cancer Center at HCI, explains how HCI's community of highly motivated and dedicated researchers, staff, and trainees is focused on one thing: eradicating suffering caused by cancer.
Clinical trials test the safety and effectiveness of new cancer drugs and treatments. They help us find better ways to prevent, diagnose, or treat cancer. At any given time, Huntsman Cancer Institute has an average of 200 clinical trials open to cancer patients.
The Center of Excellence in Hematologic Malignancies and Hematology at Huntsman Cancer Institute is a group of more than three dozen doctors and scientists dedicated to hematologic cancers such as leukemia, lymphoma, and multiple myeloma. Integration and collaboration across disciplines will improve clinical care and advance research in these complicated diseases.
In less than three years, HCI researchers have taken an idea from concept to lab to clinical evaluation. Conan Kinsey, MD, PhD, and Martin McMahon, PhD, combined two drugs that had not been used in combination before to treat pancreatic tumors. The results were promising and they were able to move from the lab to clinical trial quickly. A clinical trial to test the safety and effect of this drug combination in pancreatic cancer is now underway at HCI and planned at other sites around the United States.
The American Society of Clinical Oncology recently published Clinical Cancer Advances, their 2019 annual report on the progress against cancer. The report examines the most transformative research of the past year and looks ahead to future research priorities. Two physician-scientists from Huntsman Cancer Institute contributed to the report.
HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Thomas Varghese Jr, MD, MS, was recently honored with a Huntsman Translational Scholar award.
Huntsman Cancer Institute (HCI) at the University of Utah (the U) has appointed Ignacio Garrido-Laguna, MD, PhD, as director of its Phase I Clinical Trials unit. In this position, Garrido-Laguna will oversee all aspects of HCI’s Phase I clinical trials.
The Lung Cancer Research Foundation (LCRF) announced the awardees of its 2018 Scientific Grant Program today during the Thirteenth Annual Lung Cancer Awareness Luncheon, held at The Pierre in New York City. Through this program, LCRF awarded $1.95 million in research grants to 13 investigators for innovative research focused on the prevention, diagnosis, and treatment of lung cancer. LCRF received a record-breaking 201 grant applications, representing 116 institutions and 21 countries in 2018.
Just a little way down the hill from Huntsman Cancer Institute, the Zangle Lab in the Department of Chemical Engineering is working on new technologies to choose the most effective therapies for each individual patient with breast cancer. We are excited about a project that takes a new approach to measure the growth of cancer cells and predict which drugs may be most beneficial to patients with advanced metastatic breast cancer.
By unraveling the link between obesity and gastrointestinal cancers, researchers hope to develop effective treatments and strategies for lowering cancer risk. A team of scientists at Huntsman Cancer Institute published a wide review of findings on the biological links between obesity and gastrointestinal cancers. They also examined studies on how diet, exercise, and other weight-related interventions may help reverse this connection.
African American men experience significant health disparities. They are almost twice as likely to be diagnosed with prostate cancer as white men, yet they are underrepresented in prostate cancer research. A new study by Charles R. Rogers, PhD, MPH, MS, CHES®, uncovers attitudes toward prostate cancer research among African American men and suggests strategies to increase participation in research. The study is included in a new collection of research on health disparities impacting African American men.
Women who reported recent, regular use of low-dose aspirin had a 23% lower risk of ovarian cancer when compared with women who did not regularly take aspirin, according to research led by Mollie Barnard, ScD, a postdoctoral fellow at Huntsman Cancer Institute.
Dear patients, please know this as you go through your treatment journey: the dedicated technical staff, PhD students, and postdoctoral fellows in Dr. Alana Welm's lab continue to work hard every day (and night!) to bring new hope to breast cancer through innovative research, always with patients in mind.
Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Ignacio Garrido-Laguna, MD, PhD, is a physician-scientist who treats patients with pancreatic cancer.
Every year, we open our doors to share our mission and educate our community about cancer prevention and research.
The PathMaker program is a stepping stone for students interested in a career in health sciences or STEM with backgrounds underrepresented in the biomedical workforce.
Study of Utah Lung Cancer Patients Finds Those Who Never Smoked May Have Genetic Predisposition for Cancer
Despite Utah's low smoking rate, lung cancer remains the leading cause of cancer death in Utah. In addition, lung cancer in people who have used tobacco and people who have never smoked behaves differently. Researchers at Huntsman Cancer Institute wanted to know why.